Spike Protein Detox
Given the pathogenicity of the spike protein, targeting it is a viable strategy for those experiencing residual symptoms from both the vaccine and infection as well as day-to-day exposure. The spike protein can persist in the body for a very long time because it is resistant to proteolytic cleavage and removal.
Unfortunately, the body does not have enzymes to properly break down or degrade the spike protein and rid it from the body, so how do we get rid of it? There are promising nutraceuticals in the cleavage and detox of the spike protein of the body, offering hope for those experiencing its damaging effects. Present day, the majority of the global population has had COVID and/or had at least one COVID vaccine. Many are experiencing chronic disabling symptoms from both COVID infection and vaccination. The coronavirus spike protein has been implicated in the development of these long-term symptoms, often referred to as long COVID or post-COVID vaccination syndrome.
Many are walking around today still with the spike protein in their cells and tissues – an insidious cause of damage. Many are left suffering as there is no accepted protocol for treatment. The first spike protein detoxification protocol to be published in medical literature, written by Peter McCullough, MD, et al., published August 25, 2023, can be read in full here: Clinical Rationale for SARS-CoV-2 Base Spike Protein Detoxification in Post COVID-19 and Vaccine Injury Syndromes.
What is the spike protein? What is its role? How can the body rid itself of the spike protein?
What is the Spike Protein?
Present on the surface of SARS-CoV-2 virus is the spike protein which is responsible for its entry into the host cell and viral replication. It has been found in various organs on autopsy after the vaccine: heart, brain, liver, ovaries, testicles, kidneys and other vital organs. The spike protein drives the development of injuries, adverse events, disabilities and death after vaccination by inciting inflammation and hematological effects such as thrombosis or clotting. There have been cases of thrombotic injury secondary to the vaccine in which the spike protein has been discovered within the blood clot itself.
After severe COVID, evidence suggests the spike protein can continue to replicate in the tissues for months to years. After the COVID vaccine, the genetic code for the spike protein is delivered to the body where various cells in tissues continue to produce spike protein. This is of particular concern with each subsequent shot as there is an accumulation of spike protein in the body with an uncontrolled duration. Even if you do not carry on to have post-infection or vaccination symptoms, the spike protein may still linger in your body. As your own cells can produce the spike protein after vaccination, your immune system targets your own cells in an effort to destroy the spike protein which can also be a cause of autoimmune processes.
The immune system produces IgG against the spike protein. IgG rise against the spike protein is greater after exposure to the vaccine than infection as there is greater exposure to spike protein from vaccination. Long-COVID has been associated with anti-spike IgG levels and persistent circulating spike protein. This is different than long-lasting immunity from natural infection. Some individuals carry on to develop organ injury due to the accumulation of the spike protein and the immune system’s inability to neutralize it. An example of such organic injury is the heart with myocarditis in young adults and children.
Nattokinase
The most promising nutraceutical at this point in the degradation of the spike protein is nattokinase, a proteolytic enzyme derived from the fermentation of soy beans by the probiotic Bacillus subtilis natto. Nattokinase has a long history of use in Japan for antithrombotic and atherosclerotic properties. Those on blood thinning medications should be aware of its anticoagulant effect and can safely consume it with physician monitoring.
In preclinical models, nattokinase stopped SARS-CoV-2 cells in culture. Another study demonstrated degradation of the spike protein in SARS-CoV-2-infected cells. The only nattokinase to have published data on safety and efficacy is NSK-SD so look for a product with that specification.
Dosage: 2,000 FU (100 mg) twice daily
Other Potential Agents
Other potential nutraceuticals and medications aiding in neutralizing and/or inhibiting the spike protein include:
- Methylene blue: 0.5-1 mg/kg/day. Enhanced with red light therapy
- Bromelain: 500mg daily
- Curcumin (nano or liposomal): 500mg twice daily
- N-acetylcysteine (NAC): 400-1000mg daily
- Pine needle tea: 3x daily
- Ivermectin: Variable dosing; 0.4mg/kg weekly x 4 weeks, 0.2-0.3mg/kg daily
- Hydroxychloroquine (with zinc): Variable dosing; 200mg weekly x 4 weeks, 200mg once or twice daily
- Green tea extract (EGCG): 150mg twice daily
- Dandelion extract: 50mg twice daily
- Irish sea moss: 500mg twice daily
- Nigella sativa (black cumin): 500mg twice daily
Conclusion
The coronavirus spike protein is implicated as the driving force of residual damage and long symptoms from both infection and vaccination. Degrading and expelling the spike protein from the body is difficult due to its resistance to cleavage. At this point in time, various agents hold promise and may benefit those suffering with spike protein-driven syndromes.
Have an Awesome Day! Dr D and Drew Chernisky, PA